What is SignPost?

SignPost Cancer Dx Inc. was started by Induran Ventures Inc., to create BreastDefense.

SignPost - is at the very forefront - globally in the development of a molecular diagnostic for breast cancer. This single-minded focus on product development gives SignPost maximum efficiency in the use of time and capital.

Strategic collaboration with both Dynacare and LabCorp, and a team of researchers at Queen’s University, is a fundamental element in the business model.